Feature|Articles|September 29, 2025

What urologists can expect in Q4 of 2025

Author(s)Benjamin P. Saylor, Strategic Content Lead, Hannah Clarke

Fact checked by: Benjamin P. Saylor, Strategic Content Lead

A comprehensive guide to the key regulatory decisions and conferences slated for the last few months of the year.

As we enter the final months before the end of 2025, we reflect on the notable advances that have already shifted the landscape in urologic care. Looking back at this year, we saw notable approvals across bladder cancer, prostate cancer, and benign conditions.